Gaudenz von Capeller
CFO at Cellestia Biotech- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Cellestia Biotech
-
Switzerland
-
Biotechnology Research
-
1 - 100 Employee
-
CFO
-
Jul 2017 - Present
Basel Area, Switzerland Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having… Show more Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland. - Built company structure from sratch - Raised USD 55 Mio in Equity Show less
-
-
-
-
CFO
-
Dec 2012 - Jun 2017
Basel Area, Switzerland - Built company from scratch - Raised USD 50 Mio equity
-
-
-
-
Board Member
-
Nov 2010 - Dec 2013
Luxembourg - Manage Real Estate Company - Negotiate Loans with local banks
-
-
-
Helvetica Property Group
-
Switzerland
-
Real Estate
-
1 - 100 Employee
-
CFO
-
Jul 2010 - Dec 2013
- Prepare IPO at SIX, which led to M&A with Partners Group - Negotiate Loans and Mortgages > USD 300 Mio - Run Finance and HR
-
-
-
CARBOGEN AMCIS
-
Switzerland
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Managing Director
-
Jun 2008 - Feb 2010
- Lead Swiss Local Management Team - Integration into parent organization post merger
-
-
Finance Director
-
Jun 2003 - May 2008
Switzerland - Trade sale to Dishman Pharmaceuticals, India - Turnaround of Swiss Business post CH11 of US Parent
-
-
-
BroadVision, Inc
-
United States
-
Software Development
-
1 - 100 Employee
-
EMEA Controller
-
1998 - 2003
- Built European Finance organization - Set up shared service center for 6 legal entities
-
-
-
UBS
-
Switzerland
-
Financial Services
-
700 & Above Employee
-
Controller
-
1993 - 1998
-
-
Education
-
IMD Business School
-
University of Basel
-
Bäumlihof Gymnasium
-
Bäumlihof Gymnasium
-
Hochschule für Wirtschaft FHNW / School of Business FHNW
-
University of Applied Sciences Basel
Finance and Controlling